Compare PMCB & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMCB | ICON |
|---|---|---|
| Founded | 1996 | 2023 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 4.7M |
| IPO Year | N/A | 2024 |
| Metric | PMCB | ICON |
|---|---|---|
| Price | $0.74 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | ★ 7.4M | 124.7K |
| Earning Date | 12-18-2025 | 04-02-2026 |
| Dividend Yield | N/A | ★ 1401.94% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,449,000.00 |
| Revenue This Year | N/A | $128.63 |
| Revenue Next Year | N/A | $10.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 96.44 |
| 52 Week Low | $0.63 | $0.55 |
| 52 Week High | $1.90 | $93.19 |
| Indicator | PMCB | ICON |
|---|---|---|
| Relative Strength Index (RSI) | 40.11 | 35.58 |
| Support Level | $0.68 | $0.65 |
| Resistance Level | $0.78 | $0.77 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 15.65 | 45.34 |
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.